Double Blind Study of Intrathecal Beta-Interferon in Multiple Sclerosis: Clinical and Laboratory Results.

Journal of Neurology, Neurosurgery and Psychiatry - United Kingdom
doi 10.1136/jnnp.53.7.554
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Intrathecal Interferon for Multiple Sclerosis

Science
MultidisciplinaryPhilosophy of ScienceHistory
1982English

Treatment Recommendations for Interferon-Beta in Multiple Sclerosis

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1999English

Erythema Elevatum Et Diutinum, Multiple Sclerosis and Interferon Beta

Dermatology
Dermatology
2004English

Alternative Statistical Methods for Estimating Efficacy of Interferon Beta-1b for Multiple Sclerosis Clinical Trials

BMC Medical Research Methodology
EpidemiologyHealth Informatics
2011English

Cytokines and Intrathecal IgG Synthesis in Multiple Sclerosis Patients During Clinical Remission

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2005English

Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy

Multiple Sclerosis
Neurology
2011English

Assessing the Long-Term Effectiveness of Interferon-Beta and Glatiramer Acetate in Multiple Sclerosis: Final 10-Year Results From the UK Multiple Sclerosis Risk-Sharing Scheme

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2018English

Multiple Sclerosis-Linked and Interferon-Beta-Regulated Gene Expression in Plasmacytoid Dendritic Cells

Journal of Neuroimmunology
AllergyImmunologyNeurology
2012English

T-Cell Interferon Gamma Receptor Binding in Interferon Beta-1b–Treated Patients With Multiple Sclerosis

Archives of Neurology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy